Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2024 Mar 2:61:69-71.
doi: 10.1016/j.jdcr.2024.02.015. eCollection 2025 Jul.

Stabilization of frontal fibrosing alopecia with topical latanoprost monotherapy

Sarah Alenezi  1 , Mariya I Miteva  1
Affiliations
Case Reports

Stabilization of frontal fibrosing alopecia with topical latanoprost monotherapy

Sarah Alenezi et al. JAAD Case Rep. .
No abstract available

Keywords: frontal fibrosing alopecia; latanoprost; monotherapy; prostaglandin analog; scarring alopecia.

PubMed Disclaimer

Conflict of interest statement

None disclosed.

Figures

Fig 1
Fig 1
Clinical image of the frontal aspect of the scalp using FotoFinder videodermatoscopy. A, Pretreatment: Decreased hair density with hairline reduction. B, Posttreatment: Notable absence of progressive hairline reduction or skin thinning, following therapy with topical latanoprost 0.005% solution at the 10-month mark.
Fig 2
Fig 2
Clinical image of the temporal scalp using FotoFinder videodermatoscopy. A, Pretreatment: Decreased hair density with hairline reduction. B, Posttreatment: Increase in hair thickness with notable absence of progressive hairline reduction or skin thinning, following therapy with topical latanoprost 0.005% solution at the 10-month mark.
See this image and copyright information in PMC

References

    1. Porriño Bustamante M.L. Clinical, Quality of Life and Histopathologic Analyses. Universidad de Granada; Granada: 2022. Frontal Fibrosing Alopecia.
    1. Imhof R., Tolkachjov S.N. Optimal management of frontal fibrosing alopecia: a practical guide. Clin Cosmet Investig Dermatol. 2020;13:897–910. - PMC - PubMed
    1. Blume-Peytavi U., Lönnfors S., Hillmann K., Bartels N.G. A randomized double-blind placebo-controlled pilot study to assess the efficacy of a 24-week topical treatment by latanoprost 0.1% on hair growth and pigmentation in healthy volunteers with androgenetic alopecia. J Am Acad Dermatol. 2012;66(5):794–800. - PubMed
    1. Mumford B.P., Eisman S., Yip L. Acquired causes of eyebrow and eyelash loss: a review and approach to diagnosis and treatment. Australas J Dermatol. 2023;64(1):28–40. - PubMed
    1. Cohen J.L. Enhancing the growth of natural eyelashes: the mechanism of bimatoprost-induced eyelash growth. Dermatol Surg. 2010;36(9):1361–1371. - PubMed

Publication types

LinkOut - more resources